<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02942394</url>
  </required_header>
  <id_info>
    <org_study_id>SONIS15473</org_study_id>
    <nct_id>NCT02942394</nct_id>
  </id_info>
  <brief_title>Treatment of the Postthrombotic Syndrome With the Oblique Stent - TOPOS Study</brief_title>
  <official_title>Non-interventional, Multicenter, Multinational Venous Stent Study for the Treatment of the Post-thrombotic Syndrome With Common Iliac Vein Compression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Optimed Medizinische Instrumente GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Optimed Medizinische Instrumente GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary objective:&#xD;
&#xD;
      To assess the efficacy of the stents (sinus-Obliquus stent for the common iliac vein, the&#xD;
      sinus-XL Flex stent or sinus-Venous stent for the external iliac and common femoral veins) by&#xD;
      evaluating different gradations of patency rates, patient's rating of disease severity and&#xD;
      quality of life in patients with post-thrombotic syndrome and concomitant common iliac vein&#xD;
      compression.&#xD;
&#xD;
      Secondary objective:&#xD;
&#xD;
      To assess long-term safety of venous stenting&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Actual">December 17, 2020</completion_date>
  <primary_completion_date type="Actual">December 17, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Patency Rate</measure>
    <time_frame>After 3 months up to a follow-up of 2 years.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Primary Assisted Patency Rate</measure>
    <time_frame>After 3 months up to a follow-up of 2 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Patency Rate</measure>
    <time_frame>After 3 months up to a follow-up of 2 years.</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">60</enrollment>
  <condition>Post-thrombotic Syndrome</condition>
  <condition>Iliac Vein Compression Syndrome</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sinus-Obliquus Stent System</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with post-thrombotic syndrome and concomitant common iliac vein compression.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female adults aged ≥18 years&#xD;
&#xD;
          2. Post-thrombotic syndrome (Villalta score &gt;4 points) due to iliac vein thrombosis with&#xD;
             or without femoral deep vein thrombosis&#xD;
&#xD;
          3. Evidence of venous stenosis in common iliac vein &gt;50% confirmed by venography (CT or&#xD;
             MRI) or intravascular ultrasound (IVUS)&#xD;
&#xD;
          4. Use of sinus-Obliquus stent for unilateral common iliac vein stenosis&#xD;
&#xD;
          5. If stent extension is required either sinus-XL Flex or sinus-Venous stents must have&#xD;
             been used for stenoses &gt;50% confirmed by venography (CT or MRI) or IVUS in external&#xD;
             iliac and common femoral veins&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnancy, breast-feeding or birth-giving during the last 30 days&#xD;
&#xD;
          2. Life expectancy &lt;6 months&#xD;
&#xD;
          3. Iliofemoral DVT less than 3 months ago&#xD;
&#xD;
          4. Permanently immobile patient (wheelchair user or bed-ridden patient)&#xD;
&#xD;
          5. Allergy to Nitinol&#xD;
&#xD;
          6. Patient's target vessel(s) has/have been stented before&#xD;
&#xD;
          7. Legal incapacity and/or other circumstances rendering the patient unable to understand&#xD;
             the nature, scope and possible impact of the study&#xD;
&#xD;
          8. Patients in custody by juridical or official order&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nils Kucher, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director Clinic for Angiology Universitätsspital Zürich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus der Stadt Wien</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinen Hospital Arnsberg</name>
      <address>
        <city>Arnsberg</city>
        <zip>59759</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitätsklinik Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universität des Saarlandes</name>
      <address>
        <city>Homburg</city>
        <zip>66424</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht University Hospital MUMC+</name>
      <address>
        <city>Maastricht</city>
        <zip>6229</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>INSELSPITAL, Universitätsspital Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Zürich</name>
      <address>
        <city>Zürich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>October 19, 2016</study_first_submitted>
  <study_first_submitted_qc>October 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 24, 2016</study_first_posted>
  <last_update_submitted>January 11, 2021</last_update_submitted>
  <last_update_submitted_qc>January 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postthrombotic Syndrome</mesh_term>
    <mesh_term>Postphlebitic Syndrome</mesh_term>
    <mesh_term>May-Thurner Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

